Search fresh public links, source activity, and ready-to-use post angles for Advanced Breast Cancer.
Fresh curated links around advanced breast cancer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
By: Liz Highleyman From: cancerhealth.com The Food and Drug Administration (FDA) recently approved several new therapies for breast cancer, including for patients with metastatic (...
By: Ashling Wahner From: onclive.com Key Takeaways Indication targets endocrine-pretreated metastatic HR-positive/HER2-negative disease specifically without PIK3CA mutations, posit...
The FDA has granted accelerated approval to a new treatment strategy for certain people with advanced breast cancer—one that can begin after a resistance mutation...
By: Mike Basset From: medpagetoday.com About 110,000 new cases of leptomeningeal disease (metastases of cerebrospinal fluid or the thin membranes that surround the brain and spinal...
From: oncodaily.com For patients with hormone receptor–positive metastatic breast cancer, the therapeutic landscape has expanded dramatically. CDK4/6 inhibitors transformed first-l...
From: oncnursingnews.com On June 24, the U.S. Food and Drug Administration (FDA) announced the approval of palbociclib (Ibrance) for a new indication in the oncology space. This ap...
From: .onclive.com The FDA has granted fast track designation to ETX-19477 for the treatment of adult patients with BRCA-mutated, hormone receptor (HR)–positive, HER2-negative unre...
TUESDAY, Sept. 8, 2026 — The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors have found a way around their...
From:.cancerconnect.com Every year, thousands of cancer researchers and doctors gather at the annual meeting of the American Society of Clinical Oncology (ASCO) to share the latest...
From: oncodaily.com For years, first-line treatment for metastatic triple-negative breast cancer has been shaped by a difficult divide. Patients whose tumors express PD-L1 and are...
Source: Dana-Farber Cancer Institute From news-medical.net The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with “double-positive” metast...
From: healthline.com When breast cancer spreads to other areas, it’s called metastatic, or stage 4, breast cancer. Breast cancer can spread to your bones, lungs, liver, and brain,...
TUESDAY, Aug. 25, 2026 — A new approach to treating metastatic breast cancer may allow some patients to avoid chemotherapy, at least initially. In a small early-stage trial recentl...
From: healthline.com Key Takeaways ER-positive breast cancer means cancer cells have estrogen receptors that promote tumor growth when bound to estrogen. It is the most common type...
From: aacr.org/patients-com Vepdegestrant is the first PROTAC approved for any cancer indication. The U.S. Food and Drug Administration (FDA) approved vepdegestrant (Veppanu) for a...
www.againstbreastcancer.org.uk Facebook:https://www.facebook.com/againstbc/ LinkedIn: https://www.linkedin.com/company/against-breast-cancer Instagram: @againstbreastcancer1 Pi...
www.breastcancernow.org Twitter: @breastcancernow Primary research areas Cancer Grant types Infrastructure, Postgraduate studentship, Programme (typically >4 years), P...
By: Ashley Welch From: everydayhealth.com While traveling with metastatic breast cancer safely and confidently is completely possible, it involves a bit of planning. Before you set...
In a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, turning a contentious regulatory review into a landmark win...
By: Dr. Chinta Sidharthan From: azolifesciences.com In a recent study published in Cell Death & Differentiation, researchers found that tumor-associated macrophages supply the...
By: Erica Stringer-Reasor, MD From: targetedonc.com The FDA has approved gedatolisib (Revtorpyk), the first dual PI3K/mTOR pathway inhibitor, for patients with hormone receptor–pos...
By:Sara A. Hurvitz, MD, Sabrina Seran From: targetedonc.com On July 14, 2026, the FDA approved gedatolisib (Revtorpyk) in combination with fulvestrant (Faslodex), with or without p...
A 29-year-old teacher and mother of five is sharing her experience with stage 3 breast cancer, encouraging others to advocate for their health as she prepares for another surgery.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.